ID

39745

Description

Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV); ODM derived from: https://clinicaltrials.gov/show/NCT01316185

Link

https://clinicaltrials.gov/show/NCT01316185

Keywords

Versions (1)
  1. 2/15/20 2/15/20 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

February 15, 2020

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Hepatitis D NCT01316185

English

Eligibility Hepatitis D NCT01316185

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. men and women age 18 or older with the capacity to give written informed consent
Description

Age | Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0021430
2. patients with compensated chronic hdv infection as indicated by presence of anti-hdv in serum.
Description

Chronic hepatitis D infection Compensated | Hepatitis D antibody Serum

Data type

boolean

Alias
UMLS CUI [1,1]
C2074980
UMLS CUI [1,2]
C0205432
UMLS CUI [2,1]
C0312635
UMLS CUI [2,2]
C0229671
3. liver biopsy should be performed within one-year of study screening and graded using the knodell scoring system.
Description

Biopsy of liver | Knodell Fibrosis Score

Data type

boolean

Alias
UMLS CUI [1]
C0193388
UMLS CUI [2]
C3898641
4. presence of hdv antigen in liver tissue or hdv-rna in serum.
Description

Hepatitis delta Antigens Liver parenchyma | Hepatitis D virus RNA Serum

Data type

boolean

Alias
UMLS CUI [1,1]
C0057317
UMLS CUI [1,2]
C0736268
UMLS CUI [2,1]
C0486926
UMLS CUI [2,2]
C0229671
5. active hbv replication will not exclude patients.
Description

Hepatitis B Virus Replication

Data type

boolean

Alias
UMLS CUI [1,1]
C0019169
UMLS CUI [1,2]
C0042774
6. previous therapy with standard alpha-interferon or peginterferon will not exclude patients.
Description

Prior Therapy | Interferon-alpha | PEGINTERFERON

Data type

boolean

Alias
UMLS CUI [1]
C1514463
UMLS CUI [2]
C0002199
UMLS CUI [3]
C0982327
7. patients who are hbv therapy-naïve or who previously received hbv antiviral therapy will be eligible. patients currently taking hbv antiviral therapy will e considered on a case basis.
Description

Therapy naive Hepatitis B Virus | Antiviral Therapy Hepatitis B Virus

Data type

boolean

Alias
UMLS CUI [1,1]
C0919936
UMLS CUI [1,2]
C0019169
UMLS CUI [2,1]
C0280274
UMLS CUI [2,2]
C0019169
8. female subjects of reproductive potential and female partners of male subjects should be on two reliable forms of contraception from the start of the study until 60 days from the end of ebp921 dosing.
Description

Childbearing Potential Contraceptive methods Quantity | Gender Partner Contraceptive methods Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [1,3]
C1265611
UMLS CUI [2,1]
C0079399
UMLS CUI [2,2]
C0682323
UMLS CUI [2,3]
C0700589
UMLS CUI [2,4]
C1265611
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. severe neuropsychiatric disorders
Description

Neuropsychiatric syndrome Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C3203509
UMLS CUI [1,2]
C0205082
2. history or clinical manifestations of significant metabolic, hematological, pulmonary, ischemic heart disease, significant or unstable heart disease, gastrointestinal, neurological, renal, urological, endocrine, ophthalmologic disorders including severe retinopathy, or immune-mediated disease
Description

Metabolic Disease | Hematological Disease | Lung disease | Myocardial Ischemia | Heart Disease | Heart Disease Unstable | Gastrointestinal Disease | Nervous system disorder | Kidney Disease | Urologic Disease | Endocrine System Disease | Disorder of eye | Retinal Disease Severe | Disease Immune-mediated

Data type

boolean

Alias
UMLS CUI [1]
C0025517
UMLS CUI [2]
C0018939
UMLS CUI [3]
C0024115
UMLS CUI [4]
C0151744
UMLS CUI [5]
C0018799
UMLS CUI [6,1]
C0018799
UMLS CUI [6,2]
C0443343
UMLS CUI [7]
C0017178
UMLS CUI [8]
C0027765
UMLS CUI [9]
C0022658
UMLS CUI [10]
C0042075
UMLS CUI [11]
C0014130
UMLS CUI [12]
C0015397
UMLS CUI [13,1]
C0035309
UMLS CUI [13,2]
C0205082
UMLS CUI [14,1]
C0012634
UMLS CUI [14,2]
C4330477
3. pregnant or breast-feeding patients or the inability to practice adequate contraception during the conduct of the study
Description

Pregnancy | Breast Feeding | Contraceptive methods Unable

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C0700589
UMLS CUI [3,2]
C1299582
4. underlying autoimmune/immune-deficiency disease (e.g., lupus, sarcoidosis, celiac disease, hiv antibody positive, aids)
Description

Autoimmune Diseases | Immunologic Deficiency Syndromes | Lupus Erythematosus | Sarcoidosis | Celiac Disease | HIV antibody positive | AIDS

Data type

boolean

Alias
UMLS CUI [1]
C0004364
UMLS CUI [2]
C0021051
UMLS CUI [3]
C0409974
UMLS CUI [4]
C0036202
UMLS CUI [5]
C0007570
UMLS CUI [6]
C0920548
UMLS CUI [7]
C0001175
5. chronic (> 4 weeks duration) diarrhea
Description

Chronic diarrhea Duration

Data type

boolean

Alias
UMLS CUI [1,1]
C0401151
UMLS CUI [1,2]
C0449238
6. body weight > 128 kg and < 40 kg
Description

Body Weight

Data type

boolean

Alias
UMLS CUI [1]
C0005910
7. uncompensated cirrhosis
Description

Liver Cirrhosis Uncompensated

Data type

boolean

Alias
UMLS CUI [1,1]
C0023890
UMLS CUI [1,2]
C0205433
8. absolute neutrophil count less than 1500 per cubic millimeter
Description

Absolute neutrophil count

Data type

boolean

Alias
UMLS CUI [1]
C0948762
9. platelet count less than 90,000 per cubic millimeter
Description

Platelet Count measurement

Data type

boolean

Alias
UMLS CUI [1]
C0032181
10. evidence of concurrent hcv infection with positive serum hcvrna
Description

Hepatitis C | Serum Hepatitis C RNA positive

Data type

boolean

Alias
UMLS CUI [1]
C0019196
UMLS CUI [2,1]
C0229671
UMLS CUI [2,2]
C0855842
11. evidence of hepatocellular carcinoma
Description

Liver carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C2239176
12. active substance abuse (alcohol, inhaled or injected drugs) within the past 12 months
Description

Substance Use Disorders

Data type

boolean

Alias
UMLS CUI [1]
C0038586
13. diagnosis of malignancy in the previous five years excluding superficial dermatologic malignancies
Description

Malignant Neoplasms | Exception Malignant neoplasm of skin Superficial

Data type

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0007114
UMLS CUI [2,3]
C0205124
14. any experimental therapy in the previous 6 months prior to enrollment.
Description

Therapy, Investigational

Data type

boolean

Alias
UMLS CUI [1]
C0949266
16. patients with a history of multiple drug resistant hbv 17. patients receiving interferon therapy for any reason.
Description

Multi-Drug Resistance HBV | Interferon therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0242640
UMLS CUI [1,2]
C0019169
UMLS CUI [2]
C0279030
Back to the top of the page

Similar models

Eligibility Hepatitis D NCT01316185

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age | Informed Consent
Item
1. men and women age 18 or older with the capacity to give written informed consent
boolean
C0001779 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
Chronic hepatitis D infection Compensated | Hepatitis D antibody Serum
Item
2. patients with compensated chronic hdv infection as indicated by presence of anti-hdv in serum.
boolean
C2074980 (UMLS CUI [1,1])
C0205432 (UMLS CUI [1,2])
C0312635 (UMLS CUI [2,1])
C0229671 (UMLS CUI [2,2])
Biopsy of liver | Knodell Fibrosis Score
Item
3. liver biopsy should be performed within one-year of study screening and graded using the knodell scoring system.
boolean
C0193388 (UMLS CUI [1])
C3898641 (UMLS CUI [2])
Hepatitis delta Antigens Liver parenchyma | Hepatitis D virus RNA Serum
Item
4. presence of hdv antigen in liver tissue or hdv-rna in serum.
boolean
C0057317 (UMLS CUI [1,1])
C0736268 (UMLS CUI [1,2])
C0486926 (UMLS CUI [2,1])
C0229671 (UMLS CUI [2,2])
Hepatitis B Virus Replication
Item
5. active hbv replication will not exclude patients.
boolean
C0019169 (UMLS CUI [1,1])
C0042774 (UMLS CUI [1,2])
Prior Therapy | Interferon-alpha | PEGINTERFERON
Item
6. previous therapy with standard alpha-interferon or peginterferon will not exclude patients.
boolean
C1514463 (UMLS CUI [1])
C0002199 (UMLS CUI [2])
C0982327 (UMLS CUI [3])
Therapy naive Hepatitis B Virus | Antiviral Therapy Hepatitis B Virus
Item
7. patients who are hbv therapy-naïve or who previously received hbv antiviral therapy will be eligible. patients currently taking hbv antiviral therapy will e considered on a case basis.
boolean
C0919936 (UMLS CUI [1,1])
C0019169 (UMLS CUI [1,2])
C0280274 (UMLS CUI [2,1])
C0019169 (UMLS CUI [2,2])
Childbearing Potential Contraceptive methods Quantity | Gender Partner Contraceptive methods Quantity
Item
8. female subjects of reproductive potential and female partners of male subjects should be on two reliable forms of contraception from the start of the study until 60 days from the end of ebp921 dosing.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0079399 (UMLS CUI [2,1])
C0682323 (UMLS CUI [2,2])
C0700589 (UMLS CUI [2,3])
C1265611 (UMLS CUI [2,4])
Item Group
C0680251 (UMLS CUI)
Neuropsychiatric syndrome Severe
Item
1. severe neuropsychiatric disorders
boolean
C3203509 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Metabolic Disease | Hematological Disease | Lung disease | Myocardial Ischemia | Heart Disease | Heart Disease Unstable | Gastrointestinal Disease | Nervous system disorder | Kidney Disease | Urologic Disease | Endocrine System Disease | Disorder of eye | Retinal Disease Severe | Disease Immune-mediated
Item
2. history or clinical manifestations of significant metabolic, hematological, pulmonary, ischemic heart disease, significant or unstable heart disease, gastrointestinal, neurological, renal, urological, endocrine, ophthalmologic disorders including severe retinopathy, or immune-mediated disease
boolean
C0025517 (UMLS CUI [1])
C0018939 (UMLS CUI [2])
C0024115 (UMLS CUI [3])
C0151744 (UMLS CUI [4])
C0018799 (UMLS CUI [5])
C0018799 (UMLS CUI [6,1])
C0443343 (UMLS CUI [6,2])
C0017178 (UMLS CUI [7])
C0027765 (UMLS CUI [8])
C0022658 (UMLS CUI [9])
C0042075 (UMLS CUI [10])
C0014130 (UMLS CUI [11])
C0015397 (UMLS CUI [12])
C0035309 (UMLS CUI [13,1])
C0205082 (UMLS CUI [13,2])
C0012634 (UMLS CUI [14,1])
C4330477 (UMLS CUI [14,2])
Pregnancy | Breast Feeding | Contraceptive methods Unable
Item
3. pregnant or breast-feeding patients or the inability to practice adequate contraception during the conduct of the study
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0700589 (UMLS CUI [3,1])
C1299582 (UMLS CUI [3,2])
Autoimmune Diseases | Immunologic Deficiency Syndromes | Lupus Erythematosus | Sarcoidosis | Celiac Disease | HIV antibody positive | AIDS
Item
4. underlying autoimmune/immune-deficiency disease (e.g., lupus, sarcoidosis, celiac disease, hiv antibody positive, aids)
boolean
C0004364 (UMLS CUI [1])
C0021051 (UMLS CUI [2])
C0409974 (UMLS CUI [3])
C0036202 (UMLS CUI [4])
C0007570 (UMLS CUI [5])
C0920548 (UMLS CUI [6])
C0001175 (UMLS CUI [7])
Chronic diarrhea Duration
Item
5. chronic (> 4 weeks duration) diarrhea
boolean
C0401151 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
Body Weight
Item
6. body weight > 128 kg and < 40 kg
boolean
C0005910 (UMLS CUI [1])
Liver Cirrhosis Uncompensated
Item
7. uncompensated cirrhosis
boolean
C0023890 (UMLS CUI [1,1])
C0205433 (UMLS CUI [1,2])
Absolute neutrophil count
Item
8. absolute neutrophil count less than 1500 per cubic millimeter
boolean
C0948762 (UMLS CUI [1])
Platelet Count measurement
Item
9. platelet count less than 90,000 per cubic millimeter
boolean
C0032181 (UMLS CUI [1])
Hepatitis C | Serum Hepatitis C RNA positive
Item
10. evidence of concurrent hcv infection with positive serum hcvrna
boolean
C0019196 (UMLS CUI [1])
C0229671 (UMLS CUI [2,1])
C0855842 (UMLS CUI [2,2])
Liver carcinoma
Item
11. evidence of hepatocellular carcinoma
boolean
C2239176 (UMLS CUI [1])
Substance Use Disorders
Item
12. active substance abuse (alcohol, inhaled or injected drugs) within the past 12 months
boolean
C0038586 (UMLS CUI [1])
Malignant Neoplasms | Exception Malignant neoplasm of skin Superficial
Item
13. diagnosis of malignancy in the previous five years excluding superficial dermatologic malignancies
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007114 (UMLS CUI [2,2])
C0205124 (UMLS CUI [2,3])
Therapy, Investigational
Item
14. any experimental therapy in the previous 6 months prior to enrollment.
boolean
C0949266 (UMLS CUI [1])
Multi-Drug Resistance HBV | Interferon therapy
Item
16. patients with a history of multiple drug resistant hbv 17. patients receiving interferon therapy for any reason.
boolean
C0242640 (UMLS CUI [1,1])
C0019169 (UMLS CUI [1,2])
C0279030 (UMLS CUI [2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial